Some distrust toward blue chips arose after the Dow Jones took a major hit in the massive volatility swings. Many health companies continue to hover toward the bottom of their 52-week range in spite of being a safer bet than the treasury's many investors are chasing.
Airlines have had a tough year and have been the victim of analyst flip flopping on their future. Their close ties with the state of the economy have discouraged buying but some of these look ripe for a contrarian buy.